CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9/Th22-related markers in the brain and periphery
Haneen A. Al‐Mazroua, Ahmed Nadeem, Mushtaq Ahmad Ansari, Sabry M. Attia, Saleh A. Bakheet, Thamer H. Albekairi, Nemat Ali, Fawaz Alasmari, Mohammad Algahtani, Abdulaziz M.S. Alsaad, Sheikh F. Ahmad
Topics & Concepts
Experimental autoimmune encephalomyelitisC-C chemokine receptor type 6ImmunologyMultiple sclerosisEncephalomyelitisCD3BiologySpleenChemokineChemokine receptorMedicineImmune systemCD8Cytokine Signaling Pathways and InteractionsMultiple Sclerosis Research StudiesT-cell and B-cell Immunology